Invossa
Search results
Scope
Date
~
-
PharmeceuticalsKolon resumes Invossa phase 3 clinical trials in US
Kolon TissueGene Inc., the cell therapies unit of South Korean pharmaceutical company Kolon Life Science Inc., said on Dec. 28 it has resumed admi...
Dec 28, 2021 (Gmt+09:00)
1
Latest News
- 1 Mubadala, Goldman Sachs to invest $700 mn in Kakao Mobility
- 2 Now, slim is in – and Samsung wants to be No. 1 with Galaxy S25 Edge
- 3 Hankook & Company to set up CVC with $11 mn in funding
- 4 Korea Securities Finance eyes its 1st foreign bond sale in 2026
- 5 BYD’s Atto 3 overtakes Tesla’s Model Y as best-selling EV in South Korea
